Good points Hodgie.
Efti’s method of action is unique, it’s not a checkpoint inhibitor which is Imugene’s line of attack and many other Lag3 products in trial including BMS’s phase3 trial.
Efti also appears to be completely safe with no increase in toxicity in conjunction with other treatments and appears to roughly double the efficacy of existing treatments
Final results from AIPAC are big but they need to be considered in the light of TACTI 002 great results and fast track designation when arriving at a valuation. Great results will continue flowing from Tacti-002
Critical 12 month period ahead
Media, page-90
-
- There are more pages in this discussion • 654 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
0.015(4.92%) |
Mkt cap ! $464.8M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 32.5¢ | 30.0¢ | $1.168M | 3.702M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 148547 | 32.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 51809 | 2 |
View Market Depth
| Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |